Risk assessment and management of high risk familial breast cancer

Por Evans, D, Lalloo, F
Publicado em 2002

Keratoconus associated with chromosome 13 ring abnormality

Por HEAVEN, C, LALLOO, F, McHALE, E
Publicado em 2000

Update on the Manchester Scoring System for BRCA1 and BRCA2 testing

Por Evans, D, Lalloo, F, Wallace, A, Rahman, N
Publicado em 2005

Risks of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers

Por Ahmed, M, Lalloo, F, Howell, A, Evans, DG
Publicado em 2010

Sensitivity of BRCA1/2 mutation testing in 466 breast/ovarian cancer families

Por Evans, D, Bulman, M, Young, K, Gokhale, D, Lalloo, F
Publicado em 2003

Risk perception and cancer worry: an exploratory study of the impact of genetic risk counselling in women with a family history of breast cancer

Por HOPWOOD, P, SHENTON, A, LALLOO, F, EVANS, D, HOWELL, A
Publicado em 2001

Haplotype and cancer risk analysis of two common mutations, BRCA1 4184del4 and BRCA2 2157delG, in high risk northwest England breast/ovarian families

Por Evans, D, Neuhausen, S, Bulman, M, Young, K, Gokhale, D, Lalloo, F
Publicado em 2004

Non-random transmission of mutant alleles to female offspring in BRCA carriers

Por Evans, D, Shenton, A, Sharif, S, Woodward, E, Lalloo, F, Maher, E
Publicado em 2005

2157delG: a frequent mutation in BRCA2 missed by PTT

Por DAVIES, J, REDMOND, E, COX, M, LALLOO, F, ELLES, R, EVANS, D
Publicado em 2000

Low rate of TP53 germline mutations in breast cancer/sarcoma families not fulfilling classical criteria for Li-Fraumeni syndrome

Por Evans, D, Birch, J, Thorneycroft, M, McGown, G, Lalloo, F, Varley, J
Publicado em 2002

Risk algorithms that include pathology adjustment for HER2 amplification need to make further downward adjustments in likelihood scores

Por Evans, D. G., Woodward, E. R., Howell, S. J., Verhoef, S., Howell, A., Lalloo, F.
Publicado no Fam Cancer (2016)

An evaluation of common breast cancer gene mutations in a population of Ashkenazi Jews.

Por Lalloo, F, Cochrane, S, Bulman, B, Varley, J, Elles, R, Howell, A, Evans, D G
Publicado em 1998

Management of Hereditary Breast Cancer

Por Eccles, D. M., Simmonds, P., Goddards, J., Coultas, M., Lalloo, F., Evans, G., Haites, N.
Publicado em 1999

Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme

Por Amir, E, Evans, D, Shenton, A, Lalloo, F, Moran, A, Boggis, C, Wilson, M, Howell, A
Publicado em 2003

Hyperplastic Polyps Are Innocuous Lesions in Hereditary Nonpolyposis Colorectal Cancers

Por Speake, D., O'Sullivan, J., Evans, D. G., Lalloo, F., Hill, J., McMahon, R. F. T.
Publicado em 2011

Uptake of risk-reducing salpingo-oophorectomy in women carrying a BRCA1 or BRCA2 mutation: evidence for lower uptake in women affected by breast cancer and older women

Por Sidon, L, Ingham, S, Clancy, T, Clayton, R, Clarke, A, Jones, E A, Lalloo, F, Evans, D G R
Publicado em 2012

Tumour MLH1 promoter region methylation testing is an effective pre-screen for Lynch Syndrome (HNPCC)

Por Newton, K, Jorgensen, NM, Wallace, AJ, Buchanan, DD, Lalloo, F, McMahon, RFT, Hill, J, Evans, DG
Publicado no J Med Genet (2014)

A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO

Por Evans, D, Eccles, D, Rahman, N, Young, K, Bulman, M, Amir, E, Shenton, A, Howell, A, Lalloo, F
Publicado em 2004

Long-term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA1/BRCA2/TP53 status

Por Evans, D G R, Moran, A, Hartley, R, Dawson, J, Bulman, B, Knox, F, Howell, A, Lalloo, F
Publicado em 2010

Menopausal symptoms and bone health in women undertaking risk reducing bilateral salpingo-oophorectomy: significant bone health issues in those not taking HRT

Por Challberg, J, Ashcroft, L, Lalloo, F, Eckersley, B, Clayton, R, Hopwood, P, Selby, P, Howell, A, Evans, D G
Publicado em 2011